Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
Q3 2022 vs. Q2 2022
How the institutions holding Prenetics Global Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 11 | 10 | −1 |
| Shares | 5.91M | 5.71M | −194.9K (−3.3%) |
| Value | $23.9M | $21.6M | −$2.27M (−9.5%) |
New holders (2)
Institutions that held Prenetics Global Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vident Investment Advisory, LLC | 16,218 | $61.0K | 0.00% |
| Wolverine Asset Management LLC | 226 | $0 | 0.00% |
Sold out (3)
Institutions that held Prenetics Global Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 11,740 | $47.0K |
| Penserra Capital Management LLC | 4,736 | $19.0K |
| UBS Group AG | 1,704 | $7.00K |